Clover Health Investments (CLOV) EBIT (2019 - 2026)

Clover Health Investments (CLOV) has 8 years of EBIT data on file, last reported at $27.3 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT rose 2245.53% year-over-year to $27.3 million; the trailing twelve-month figure through Mar 2026 stood at -$56.9 million (down 134.05% YoY), and the FY2025 full-year result was -$85.5 million, down 86.95% from the prior year.
• EBIT for Q1 2026 stood at $27.3 million, up from -$49.3 million in the prior quarter.
• Across five years, EBIT topped out at $27.3 million in Q1 2026 and bottomed at -$102.7 million in Q2 2022.
• The 5-year median for EBIT is -$24.4 million (2025), against an average of -$35.1 million.
• The widest annual swing landed in 2025, when EBIT tumbled 246.92%; it then soared 2245.53% in 2026.
• A 5-year view of EBIT shows it stood at -$22.4 million in 2022, then slumped by 182.35% to -$63.1 million in 2023, then jumped by 66.03% to -$21.4 million in 2024, then slumped by 129.95% to -$49.3 million in 2025, then surged by 155.42% to $27.3 million in 2026.
• The last three EBIT figures came in at $27.3 million (Q1 2026), -$49.3 million (Q4 2025), and -$24.4 million (Q3 2025), per Business Quant data.

Peer Comparison